{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:46:41Z","timestamp":1793936801257,"version":"4.8.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Cancer Center Research and Development Fund","award":["2024-A-18"],"award-info":[{"award-number":["2024-A-18"]}]},{"name":"Grant-in-aid for Cancer Control Policy from the Ministry of Health","award":["23EA1009"],"award-info":[{"award-number":["23EA1009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study examined recent international trends in age-standardized mortality for all cancers combined and major cancer types, comparing Japan with selected countries (Australia, Canada, the Republic of Korea (Korea), the United Kingdom, and the United States of America) using the latest available national data (from 1980 through the early 2020s). Overall cancer mortality in Japan continued to decline at a pace similar to that of other high-income countries. Marked reductions were observed for stomach and liver cancers in Japan, which historically had high mortality. These declines narrowed international differences, and mortality from female liver cancer in Japan has now fallen below levels in Western countries. Stomach cancer mortality rates have been continuously decreasing in Japan, while the pace was slower than that of Korea. In contrast to those decreasing cancers, Japan showed persistently high mortality for colorectal, pancreatic, and cervical cancers. Mortality from male lung cancer and female breast cancer in Japan declined only slowly or continued to rise, resulting in levels approaching those in Western countries. The decline in liver cancer is considered an effect of measures against hepatitis B and C, and could serve as an international model. The decrease in stomach cancer is also one of Japan\u2019s progressive movements, but comparisons with Korea indicate challenges remain in secondary prevention. Strengthened primary and secondary prevention are urgently needed for colorectal, lung, female breast, and cervical cancers, which have not shown a clear decreasing tendency in Japan.<\/jats:p>","DOI":"10.1093\/jjco\/hyag029","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:29:22Z","timestamp":1770640162000},"page":"787-792","source":"Crossref","is-referenced-by-count":6,"title":["International trends in cancer mortality revisited: Japan\u2019s site-specific progress and remaining challenges until 2024"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-1269","authenticated-orcid":false,"given":"Kota","family":"Katanoda","sequence":"first","affiliation":[{"name":"Division of Population Data Science, National Cancer Center Institute for Cancer Control , Chuo-ku, Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-8802","authenticated-orcid":false,"given":"Hirokazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Population Data Science, National Cancer Center Institute for Cancer Control , Chuo-ku, Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-2393","authenticated-orcid":false,"given":"Yuri","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Faculty of Medicine, Osaka Medical and Pharmaceutical University , Takatsuki, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2026060515385916500_ref1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2188\/jea.JE20200416","article-title":"Updated trends in cancer in Japan: incidence in 1985-2015 and mortality in 1958-2018-a sign of decrease in cancer incidence","volume":"31","author":"Katanoda","year":"2021","journal-title":"J Epidemiol"},{"key":"2026060515385916500_ref2","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/jjco\/hyab139","article-title":"International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers","volume":"51","author":"Katanoda","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"2026060515385916500_ref3","year":"2025"},{"key":"2026060515385916500_ref4","volume-title":"Cancer mortality for selected sites in 24 countries (1950\u201357)","author":"Segi","year":"1960"},{"key":"2026060515385916500_ref5"},{"key":"2026060515385916500_ref6","year":"2025"},{"key":"2026060515385916500_ref7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"2026060515385916500_ref8","year":"2025"},{"key":"2026060515385916500_ref9","year":"2025"},{"key":"2026060515385916500_ref10","year":"2020"},{"key":"2026060515385916500_ref11","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3748\/wjg.v20.i6.1493","article-title":"Current progress toward eradicating helicobacter pylori in east Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026060515385916500_ref12","first-page":"292","article-title":"Current status of endoscopic gastric cancer screening in South Korea","volume":"61","author":"Lee","year":"2023","journal-title":"Journal of Gastrointestinal Cancer Screening"},{"key":"2026060515385916500_ref13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4143\/crt.2024.325","article-title":"Trends in cancer-screening rates in Korea: findings from the National Cancer Screening Survey, 2004-2023","volume":"57","author":"Kang","year":"2025","journal-title":"Cancer Res Treat"},{"key":"2026060515385916500_ref14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/09691413241240564","article-title":"Cancer screening programs in Japan: Progress and challenges","volume":"31","author":"Hamashima","year":"2024","journal-title":"J Med Screen"},{"key":"2026060515385916500_ref15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/hepr.13417","article-title":"Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view","volume":"49","author":"Tanaka","year":"2019","journal-title":"Hepatol Res"},{"key":"2026060515385916500_ref16","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.31557\/APJCP.2025.26.10.3513","article-title":"Quantifying the contribution of viral hepatitis control policies and improvement of hepatitis C treatment in Japan during 2000-2030 based on simulation modelling","volume":"26","author":"Akita","year":"2025","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026060515385916500_ref17","first-page":"100428","article-title":"Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study","volume":"22","author":"Tanaka","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"2026060515385916500_ref18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.35772\/ghm.2021.01069","article-title":"Epidemiology of viral hepatitis C: road to elimination in Japan","volume":"3","author":"Ko","year":"2021","journal-title":"Glob Health Med"},{"key":"2026060515385916500_ref19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jama.2023.25881","article-title":"Analysis of breast cancer mortality in the US-1975 to 2019","volume":"331","author":"Caswell-Jin","year":"2024","journal-title":"Jama"},{"key":"2026060515385916500_ref20","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med"},{"key":"2026060515385916500_ref21","doi-asserted-by":"publisher","first-page":"e2422513","DOI":"10.1001\/jamanetworkopen.2024.22513","article-title":"Human papillomavirus vaccination by birth fiscal year in Japan","volume":"7","author":"Yagi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026060515385916500_ref22","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/S2468-2667(20)30010-4","article-title":"Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study","volume":"5","author":"Simms","year":"2020","journal-title":"Lancet Public Health"},{"key":"2026060515385916500_ref23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.21147\/j.issn.1000-9604.2025.04.14","article-title":"Burden of pancreatic cancer among the Western Pacific region and association with human resources for health from 1990 to 2021: results from the global burden of disease study 2021","volume":"37","author":"Ning","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"2026060515385916500_ref24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"2026060515385916500_ref25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.35772\/ghm.2021.01037","article-title":"Burden of cancer attributable to modifiable factors in Japan in 2015","volume":"4","author":"Inoue","year":"2022","journal-title":"Glob Health Med"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/6\/787\/67244128\/hyag029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/6\/787\/67244128\/hyag029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:39:06Z","timestamp":1780688346000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/6\/787\/8507369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,5]]},"published-print":{"date-parts":[[2026,6,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag029","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,3,5]]}}}